Anastasis, a new mechanism driving cell survival and evolution
Project Number5DP1CA195760-02
Former Number1DP1OD019313-01
Contact PI/Project LeaderMONTELL, DENISE J.
Awardee OrganizationUNIVERSITY OF CALIFORNIA SANTA BARBARA
Description
Abstract Text
DESCRIPTION (provided by applicant): We recently discovered a new biological phenomenon, which we call anastasis (Greek for "rising to life"). Overturning the current dogma that cell death is irreversible, we found that a variety of normal and cancer cell types can reverse the process, survive, and proliferate. This reversibility takes place even after cells experience events widely believed to be points of no return, including activation of caspase enzymes and widespread DNA damage. Notably, while most cells fully recover and repair their damaged DNA, some cells retain mutations, and this increases the frequency of oncogenic transformation. The discovery of anastasis has at least five paradigm-shifting implications. First,
we suggest that anastasis represents a previously unknown cause of cancer, so inhibiting anastasis should prevent cancer. Anastasis could also offer an explanation for the longstanding observation that repeated injury increases the incidence of cancer. Second, we propose that anastasis allows tumor cells to escape chemotherapy and evolve drug resistance. Therefore, inhibiting anastasis may enhance the effectiveness of chemo- and radiation therapies and prevent relapses. Third, salvaging cells on the brink of death via anastasis may limit permanent tissue injury due to transient environmental stresses or toxin exposures. Consequently, enhancing anastasis may promote tissue regeneration. Fourth, we posit that anastasis is a cell survival mechanism that protects cells that are difficult to replace such as neurons in the adult brain or heart muscle cells, so promoting anastasis could prevent or slow degenerative diseases. Fifth, we propose that the survival of germ cells with mutations acquired through anastasis provides a mechanism to enhance genetic diversity precisely when animals are exposed to stressful environmental conditions. This could accelerate adaptation to changing environments during evolution. Here we propose to test these ideas. We designed a biosen
Public Health Relevance Statement
50-70 billion cells in the human body die each day. In contrast to the prevailing
dogma, we recently discovered a surprising ability of cells to reverse the death
process at a very late stage. Here, we propose to study the physiological
consequences and molecular mechanisms of this survival mechanism in order to
develop revolutionary new therapeutic approaches to degenerative diseases and
cancer.
No Sub Projects information available for 5DP1CA195760-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5DP1CA195760-02
Patents
No Patents information available for 5DP1CA195760-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5DP1CA195760-02
Clinical Studies
No Clinical Studies information available for 5DP1CA195760-02
News and More
Related News Releases
No news release information available for 5DP1CA195760-02
History
No Historical information available for 5DP1CA195760-02
Similar Projects
No Similar Projects information available for 5DP1CA195760-02